These scenarios are SSP2 (2021–2040), SSP3 (2021–2040 and 2041–2060), and SSP4 (2061–2080), all of which showed CIS values ranging from 0.180 to 0.346 (Figure 5). Here, SENP3 is linked to in situ carcinoma.